Glycoproteins and glycolipids are cell surface constituents, and sialic acid is a common terminal saccharide of these glycoproteins and glycolipids.' -3 Quantification of the sialic acid hydrolyzed from the attached glycoproteins and glycolipids serve as a non-specific measurement of underlying sialoglycoprotein and sialoglycolipid concentrations.' The cell surface glycoproteins and glycolipids can be released into the sera through increased turnover, secretion, and/ or shedding and are of considerable interest for their potential diagnostic and prognostic v a l~e .~.~ Since sialic acids are major constituents of glycoproteins and glycolipids, several investigators have studied their levels in the sera or plasma of patients with various disease^.'.^ Most of these studies have been concerned with total sialic acid (TSA), and/or lipid-associated sialic acid (LASA) levels. The former value includes glycoprotein-and glycolipid-bound sialic acid (as well as a small amount of free sialic acid), whereas the latter value includes only glycolipid-bound sialic acid. ' In more general studies, TSA and LASA levels have been found to be elevated in malignant diseases when compared to normal controls,'.' although elevated TSA levels have been found in inflammatory diseases and rheumatoid arthritis' as well as in Crohn's disease and psoriasis'. 
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In this study, the levels of total and lipidassociated sialic acids were determined in the sera and urine of patients with chronic glomerulonephritis (CGN) and chronic renal failure (CRF).
MATERIALS AND METHODS

Subjects
35 patients with chronic glomerulonephritis (CGN) receiving the conservative therapy. and 27 patients with chronic renal failure (CRF) attending the Haemodialysis Unit of Akdeniz University Medical Faculty form the basis of this study. CGN patients (19 males and 16 females) ranged in agc from 25 to 60 years (mean SD, 41 f 15.6 years). C R F patients ( I 6 males and 1 1 females) ranged in age from 19 to 54 years (mean f SD, 37 14.8 years). The diagnosis was based on clinical approach and relevant laboratory investigations. All the patients studied were free from malignant and inflammatory diseases. urinary obstruction, and diabctes mcllitus. Their fasting blood glucose values were within normal limits.
Sixty sera from apparently healthy people having no known disease of hepatic, renal or metabolic origin and no sign of malignancy and inflammatory diseases were analysed for the cstablishment of reference intervals. Control cases. 33 males ranged in age from 16 to 64 years (mean -t SD, 35 12.47) and 27 females ranged in age from 17 to 63 (mcan SD, 38 15.03) ycars.
Collection of blood and urine samples
Blood was collected from each of the haemodialyscd patients just before the start and at the end of the haemodialysis therapy. Blood samples from two groups of patients and healthy controls were allowed to coagulate at room tcmperature and were then centrifuged at 2000 g for IS min: the resulting sera were analysed immediately. Fresh urine samples from patients were filtered and subjected to sialic assay determination. For the determination of individual variation of sialic acid excretion, fresh urine samples were collected from a total of 40 healthy individuals with normal creatinine clearance.
Assay methods
Mcasuremc~nt of' totul siulic w i d Total sialic acid determinations were carried out by the Warren method' but with modifications to the volume of reagents used.','"." A mixture of l00/1Loftestserumorurincand 1.9mLofO.I N H2S0, was incubated for I h at 80°C. This libcrates the bound sialic acids. The mixture containing liberated, free sialic acids residues was cooled in a 20°C water bath for Smin. A l00pL aliquot of this hydrolysate was mixed with 50pL of 0.2 M sodium periodate in 9 M phosphoric acid, and the resulting oxidation was allowed to proceed at 20°C for 2Omin. The reaction was then terminated by adding 0.5 mL of a mixture of 0.8 M sodium arsenite, 0.5 M sodium sulphate, and 0.1 N HzSO,. The tubes were shaken until a yellow-brown colour disappeared. After I .S mL of 0.04 M thiobarbituric acid in 0.5 M sodium sulphate were added the mixture was placed in a boiling water bath for ISmin. The tubes were subsequently cooled in a 20°C water bath for 10 min, followed by extraction with 2.1 5 mL of cyclohexanone. The tubes were shaken and then centrifuged for Smin at 12OOg. The clear upper cyclohexanone phase was red and the colour more intense than when in water. The absorbance of the cyclohexanone layer was measured at 549 nm. The procedure was also carried out on 0.1 mL of water for the blank vessel and a series of standard solutions of N-acetylneuraminic acid (NANA). Readings were made against the blank solution. The intra-assay coefficient of variation (Yo CV) for 10 analyses was 1.8% and the interassay O/ O CV of 20 analyses was 10%.
Meusurement of' LASA Serum LASA concentration was determined by the procedure of Katopodis and Stock',5 with a slight modification in the volume of sample. Fifty microlitres of serum was placed in screw-capped tubes with 150pL water. The tubes were vortexed for 5 s and placed on ice. Three millilitres of cold ( + 4°C) chloroform/mcthanol (2: 1. v/v) was added to each tube, the tubes were capped and each tube was vortexcd for 30 s, 0 . 5 mL of cold water was added to each tube. the tubes were recapped, and all tubes were mixed for 30s by repeated inversion. All tubes were centrifuged for 5min at 12OOg at room temperature. One millilitre of the resulting upper layer containing the sialolipid fraction was transferred to another screw-capped tube. Fifty microlitres of a solution of phosphotungstic acid ( I g/mL) was added to each tube, and all tubes were vortexed and allowed to sit at room temperature for S min at 120Og. The supernatant fluids were decanted, and the remaining pellets were redissolved in I mL of 37°C distilled water by vortexing until no gross particles were seen (about 1 min).
To each tube was added 1 mL of resorcinol reagent prepared daily as follows: l 0 m L of 2% (w/v) stock resorcinol in water, 9.75 mL of water, 0.25mL of 0.1 M CuSO,, brought to a final volume of 100 mL with concentrated HCI. Each tube was capped, vortexed and placed in a 100°C boiling water bath for exactly 15 min followed by IOmin in an ice bath. Two millilitres of butyl acetateln-butanol (85: IS, v/v) was added to each tube, and the tubes were vortexed and centrifuged at room temperature for IOmin at 120Og. The extracted chromophore was read spectrophotometrically at 580 nm. For standard NANA assays, 20pL of standard NANA samples (containing 20.0 mg/dL NANA) and 9801tL of distilled water were placed into screwcapped tubes, and the tubes were vortexed and placed on ice. To each standard tube was added I mL of resorcinol and all the standard NANA tubes were then treated as LASA assay tubes.
In calculating LASA values, the final experimental value was multiplied by 1.3, a factor which allows for the volume in the extraction step. N-acetylneuraminic acid (NANA) used as standard in the assay of TSA and LASA was purchased from Sigma Chemical Co., St Louis, USA.
Other measurements Serum total lipids (TL) were assayed by the sulphophosphovanillin method (4).
All other biochemical analysis including total protein, glucose, creatinine, BUN, albumin, etc., were measured on a Dacos autoanalyser (Coulter Electronics Inc., Hialeah, USA) using the Dart reagents. 
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Statistical analysis
The relationship betwcen the variables was assessed from the correlation coefficients and the differences between the means by the Students's /-test. Standard deviation (SD) was uscd to express dispersion. A linear regression analysis was also done to determine the variation of TSA and LASA with ageing in normal male and female controls. Table I gives the mean +-SD values for TSA.
RESULTS
LASA. total lipid (TL). protein (TP). BUN and
creatinine values in the sera of normal controls and the patients with CGN and CRF. There was a statistically significant elevation of all the values except total lipids in both groups of patients as compared to the normal controls (Table I) for a tendency towards higher values in the patients.
The rise in LASA, in post-dialysis samples over that of pre-dialysis ones, although not significant might be due to the haemoconcentration that occurs during dialysis. There was no significant hyperlipidacmia in the patients (Table I ) .
The normal ranges of serum TSA and LASA levels obtained from 60 healthy subjects (33 males and 27 females) were 39.2-78.3 mg/dL (59.8 f 7.9) and 124l-174l mg/dL (15.9 f 0%). respectively. These concentrations showed no apparent dependencc on age and scx ( r = -0.1204, r = -0.1319and P > 0.05 for male and female TSA values, respectively, and r = -0.164. values in the patients and controls. Urinary total sialic acid concentrations o f patients with CGN and C R F were significantly higher than those of normal conlrols ( Table 3 ) . The values for urinary total sialic acid was expressed as nig/inL urine.
DlSCUSSlON
Tissue degradation by protcolysis is an essential part of the chronic inflammatory process. Proteinases have been implicated in the pathology of such diseases as rheumatoid arthritis, atherosclerosis, glomerulonephritis, emphysema and muscular dystrophy. Recent studies have implicated the carbohydrate moieties of glycoproteins in protection of the protein component from proteoIysis.'* This study demonstrated the elevation of serum total and lipid-associated sialic acid levels in patients with CGN and CRF maintained on regular haemodialysis. The increased levels of serum sialic acids in CGN and C R F may be the result of overproduction of serum glycoproteins. Serum levels of pyruvate are elevated in uraemia with a possible block in the production of lactate and acetyl coenzyme A. The accumulating pyruvate, through oxaloacetate can give rise to phosphoenolpyruvate, one of the precursors in the biosynthesis of N-acetyl-neuraminic acid. 4 LASA are reported to be elevated in a number of malignant condition^.',^-^ It is speculated that they reflect the releasc and accumulation of tumour products like the cell surface antigens. It is hard to imagine such a mechanism operating in renal failure. At present, the cause for LASA elevation in C R F and C G N is not clear. The findings of serum total lipids within normal limits rules out the possibility of hyperlipidaemia as a cause of elevated LASA in our patients.
There are fixed negative charges in the glomerular capillary wa11.13-15 The importance of negative charges for the glomerular permeability of charged macromolecules is well documentcd,l +.I4 Reduction in glomerular sialic acid content o f podocalyxin, the major sialoprotein o f the kidney glomerulus accounting for > 50% of the total sialic acid content of the glomerulus has been reportcd in experimental puromycin-amino nucleoside (PAN) nephrosis,"~14.'h nephrotoxic nephritis,"." autologous immune complex nephropathy (Hcymann nephritis).'' in human glomerulopathies,l' I' I' and in huinan diabetic nephropathy."."
The surplus of urinary sialoglycoproteins could originate from the serum because of loss of sclcctivity of the glomcrular filter, or could he elevated independently of thc filter damage. and be of renal origin. In previous studies, no correlation has bccn found between thc urinary sialic acid lcvels and N-acetyl-beta, D-glucosaminidase (NAG) activity, which is considered to be of renal tubular cell origin" and therefore, loss from serum is the most likely explanation. In order to clarify the underlying mechanisms further hypersialylation of serum glycoproteins and glycolipids in rcnal failure need furthcr invcstigation.
